data_1psf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1psf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.525 -0.546 . . . . 2.6400000000000001 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 97.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 1.76 109.457 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.01 -178.19 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 2.5699999999999998 109.411 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -90.06 136.61 32.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 3.9399999999999999 109.522 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.6 21.38 57.73 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.204 -1.159 . . . . 0.75 110.204 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.4 t -90.41 160.18 16.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -1.08 . . . . 0.97999999999999998 109.475 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -83.04 117.06 22.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.713 . . . . 2.54 109.247 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.75 122.18 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.564 -0.71 . . . . 1.03 109.911 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -79.33 117.35 20.23 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.581 -0.896 . . . . 1.4399999999999999 108.581 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.444 HG22 ' CE2' ' A' ' 60' ' ' PHE . 21.5 mm -64.29 131.98 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.659 -0.651 . . . . 1.03 109.636 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -119.47 31.23 6.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 1.0900000000000001 109.662 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -90.56 120.58 31.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -0.793 . . . . 2.7599999999999998 109.094 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -58.25 -61.8 2.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.464 -0.773 . . . . 2.8799999999999999 109.953 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.06 79.55 9.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.647 -0.658 . . . . 1.8899999999999999 109.367 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.81 139.86 28.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.735 . . . . 1.3999999999999999 109.608 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 19.2 t80 -65.52 -20.58 66.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.677 -0.64 . . . . 1.1599999999999999 109.861 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 7.5 m0 -121.41 28.09 7.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.94999999999999996 110.149 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 12' ' ' ARG . 14.6 t80 -63.65 139.27 58.75 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.11 -0.7 . . . . 0.95999999999999996 109.11 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -12.36 65.96 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.342 -0.932 . . . . 0.39000000000000001 110.779 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.3 159.55 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.254 . . . . 1.3999999999999999 109.485 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.19 162.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.143 -0.688 . . . . 1.03 109.143 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.24 159.68 28.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.79 -1.324 . . . . 0.27000000000000002 109.79 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -92.39 116.81 29.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.641 -0.917 . . . . 1.1000000000000001 109.462 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -51.25 125.48 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.353 -0.842 . . . . 1.1100000000000001 110.341 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.13 5.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 1.0600000000000001 109.887 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.77 159.75 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.496 -0.752 . . . . 0.87 109.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.54 164.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.113 -0.699 . . . . 1.47 109.113 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -108.01 -171.4 1.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.504 -0.747 . . . . 1.6100000000000001 109.404 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -97.06 39.38 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.533 -0.729 . . . . 4.3200000000000003 109.464 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m 59.86 30.77 20.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 4.7999999999999998 109.712 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.46 -30.41 58.43 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.522 -1.431 . . . . 2.21 109.522 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 pt -127.28 169.55 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.953 . . . . 1.6399999999999999 109.537 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.42 HG12 ' CE1' ' A' ' 34' ' ' TYR . 15.9 tt -67.38 -24.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 2.2599999999999998 109.728 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 33' ' ' ILE . 18.1 m-85 -125.93 75.84 71.35 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 1.52 109.318 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -83.41 -15.57 7.48 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.108 1.872 . . . . 0.67000000000000004 112.192 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.27 112.61 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.124 -0.985 . . . . 1.1599999999999999 110.686 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.97 120.53 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.62 -0.881 . . . . 1.28 108.62 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 22.1 t -97.88 163.68 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.507 -0.746 . . . . 1.04 109.58 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.85 137.03 46.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 3.1400000000000001 109.113 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 78.1 m-85 -128.63 -8.7 5.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.553 -0.717 . . . . 1.26 111.324 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 57.86 22.71 8.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.017 -1.052 . . . . 2.3199999999999998 109.641 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -120.92 136.61 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.908 -0.775 . . . . 2.48 108.908 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 45' ' ' TYR . 24.2 t -109.55 148.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 1.7 109.612 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -128.19 68.46 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.59 -0.694 . . . . 2.1800000000000002 109.277 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.417 ' CE2' HG12 ' A' ' 43' ' ' VAL . 45.9 m-85 -64.42 116.0 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.488 -0.757 . . . . 2.6899999999999999 109.531 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -138.98 31.06 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.625 -0.672 . . . . 4.6200000000000001 109.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 65.43 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.485 -1.446 . . . . 5.3300000000000001 109.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -108.65 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.955 . . . . 5.2699999999999996 109.484 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -176.53 125.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.563 -0.71 . . . . 7.5999999999999996 109.496 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.65 -97.1 2.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.586 -1.406 . . . . 6.8700000000000001 109.586 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -76.8 129.28 36.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.983 . . . . 7.5099999999999998 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.7 102.36 1.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.665 . . . . 5.5599999999999996 109.503 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.1 -91.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.506 -1.438 . . . . 4.4299999999999997 109.506 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.19 141.41 0.49 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.535 -1.426 . . . . 3.3900000000000001 109.535 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.92 -76.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.992 . . . . 3.2599999999999998 109.497 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 66.87 11.14 8.12 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.498 -0.751 . . . . 2.6800000000000002 110.466 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.8 p -155.25 130.13 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.172 -0.955 . . . . 1.1399999999999999 108.71 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.3 m-20 -117.64 135.52 53.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.703 . . . . 1.9399999999999999 109.768 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 9.0 m120 -71.91 148.07 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.652 -0.655 . . . . 2.2200000000000002 109.321 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 26.9 m-85 -157.99 143.81 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.247 -0.649 . . . . 0.23999999999999999 109.247 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.53 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.889 -0.782 . . . . 1.01 108.889 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.52 -48.31 81.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.484 -0.76 . . . . 1.72 109.605 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -68.93 -17.48 63.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.31 110.356 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -79.62 -20.42 46.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 1.1799999999999999 110.155 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -100.83 148.34 25.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -0.82 . . . . 1.0900000000000001 109.521 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -118.82 94.07 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 2.0499999999999998 109.249 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.0 t -58.47 106.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.497 -0.752 . . . . 1.0900000000000001 109.778 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -110.13 30.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.551 -0.718 . . . . 1.1799999999999999 109.461 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 CA-C-O 117.988 -1.451 . . . . 2.21 109.539 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.525 -0.546 . . . . 2.1299999999999999 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 97.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 1.04 109.457 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.01 -178.19 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 2.5699999999999998 109.411 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -90.06 136.61 32.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 3.3999999999999999 109.522 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.6 21.38 57.73 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.204 -1.159 . . . . 0.53000000000000003 110.204 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 24' ' ' VAL . 29.4 t -90.41 160.18 16.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -1.08 . . . . 0.45000000000000001 109.475 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -83.04 117.06 22.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.713 . . . . 2.0299999999999998 109.247 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.4 m -122.75 122.18 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.564 -0.71 . . . . 0.13 109.911 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CE ' HD21 ' A' ' 11' ' ' LEU . 3.1 ttpt -79.33 117.35 20.23 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.581 -0.896 . . . . 0.90000000000000002 108.581 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 12' ' ' ARG . 21.5 mm -64.29 131.98 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.659 -0.651 . . . . 0.12 109.636 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -119.47 31.23 6.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.29999999999999999 109.662 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -90.56 120.58 31.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -0.793 . . . . 2.0899999999999999 109.094 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -58.25 -61.8 2.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.464 -0.773 . . . . 2.3799999999999999 109.953 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.06 79.55 9.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.647 -0.658 . . . . 1.8899999999999999 109.367 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.81 139.86 28.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.735 . . . . 1.1299999999999999 109.608 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 19.2 t80 -65.52 -20.58 66.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.677 -0.64 . . . . 0.79000000000000004 109.861 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 7.5 m0 -121.41 28.09 7.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.75 110.149 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 12' ' ' ARG . 14.6 t80 -63.65 139.27 58.75 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.11 -0.7 . . . . 0.40000000000000002 109.11 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -12.36 65.96 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.342 -0.932 . . . . 0.39000000000000001 110.779 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.3 159.55 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.254 . . . . 1.3999999999999999 109.485 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 57.3 t -96.19 162.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.143 -0.688 . . . . 0.31 109.143 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -146.24 159.68 28.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.79 -1.324 . . . . 0.20999999999999999 109.79 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -92.39 116.81 29.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.641 -0.917 . . . . 0.27000000000000002 109.462 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 6' ' ' SER . 23.4 t -51.25 125.48 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.353 -0.842 . . . . 0.28999999999999998 110.341 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -97.08 -47.13 5.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.28999999999999998 109.887 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.77 159.75 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.496 -0.752 . . . . 0.63 109.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.867 HD12 HG22 ' A' ' 36' ' ' VAL . 32.2 mm -114.54 164.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.113 -0.699 . . . . 0.77000000000000002 109.113 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 27' ' ' ILE . 1.2 t70 -108.01 -171.4 1.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.504 -0.747 . . . . 1.6100000000000001 109.404 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -97.06 39.38 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.533 -0.729 . . . . 3.96 109.464 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m 59.86 30.77 20.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 4.3399999999999999 109.712 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.46 -30.41 58.43 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.522 -1.431 . . . . 1.76 109.522 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 34' ' ' TYR . 24.8 pt -127.28 169.55 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.953 . . . . 1.1100000000000001 109.537 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 34' ' ' TYR . 15.9 tt -67.38 -24.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 1.8300000000000001 109.728 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 33' ' ' ILE . 18.1 m-85 -125.93 75.84 71.35 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.93999999999999995 109.318 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 38.2 Cg_endo -83.41 -15.57 7.48 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.108 1.872 . . . . 0.67000000000000004 112.192 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 HD12 ' A' ' 27' ' ' ILE . 23.4 t -88.27 112.61 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.124 -0.985 . . . . 0.64000000000000001 110.686 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -97.97 120.53 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.62 -0.881 . . . . 0.65000000000000002 108.62 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 39' ' ' ARG . 22.1 t -97.88 163.68 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.507 -0.746 . . . . 0.23000000000000001 109.58 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -107.85 137.03 46.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 2.75 109.113 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 78.1 m-85 -128.63 -8.7 5.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.553 -0.717 . . . . 1.26 111.324 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 57.86 22.71 8.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.017 -1.052 . . . . 2.0600000000000001 109.641 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -120.92 136.61 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.908 -0.775 . . . . 2.04 108.908 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 45' ' ' TYR . 24.2 t -109.55 148.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 1.23 109.612 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -128.19 68.46 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.59 -0.694 . . . . 2.0499999999999998 109.277 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 43' ' ' VAL . 45.9 m-85 -64.42 116.0 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.488 -0.757 . . . . 2.52 109.531 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -138.98 31.06 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.625 -0.672 . . . . 4.1600000000000001 109.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 65.43 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.485 -1.446 . . . . 5.3300000000000001 109.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -108.65 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.955 . . . . 5.0899999999999999 109.484 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -176.53 125.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.563 -0.71 . . . . 7.1799999999999997 109.496 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.65 -97.1 2.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.586 -1.406 . . . . 6.5099999999999998 109.586 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -76.8 129.28 36.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.983 . . . . 7.2000000000000002 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.7 102.36 1.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.665 . . . . 5.0800000000000001 109.503 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.1 -91.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.506 -1.438 . . . . 3.8599999999999999 109.506 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.665 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 73.19 141.41 0.49 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.535 -1.426 . . . . 2.8500000000000001 109.535 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 54' ' ' GLY . 9.9 mp -115.92 -76.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.992 . . . . 2.8500000000000001 109.497 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' ' 43' ' ' VAL . 2.9 m-20 66.87 11.14 8.12 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.498 -0.751 . . . . 2.2000000000000002 110.466 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 56' ' ' ASN . 70.8 p -155.25 130.13 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.172 -0.955 . . . . 0.46999999999999997 108.71 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.3 m-20 -117.64 135.52 53.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.703 . . . . 1.5700000000000001 109.768 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' A' ' 37' ' ' ILE . 9.0 m120 -71.91 148.07 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.652 -0.655 . . . . 2.0699999999999998 109.321 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 26.9 m-85 -157.99 143.81 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.247 -0.649 . . . . 0.17000000000000001 109.247 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.53 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.889 -0.782 . . . . 0.17000000000000001 108.889 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.52 -48.31 81.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.484 -0.76 . . . . 1.72 109.605 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -68.93 -17.48 63.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.23000000000000001 110.356 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -79.62 -20.42 46.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 1.1799999999999999 110.155 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -100.83 148.34 25.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -0.82 . . . . 0.19 109.521 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 68' ' ' VAL . 20.4 tt0 -118.82 94.07 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 2.0499999999999998 109.249 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.0 t -58.47 106.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.497 -0.752 . . . . 0.28999999999999998 109.778 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.1 m -110.13 30.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.551 -0.718 . . . . 0.72999999999999998 109.461 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 CA-C-O 117.988 -1.451 . . . . 2.21 109.539 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.525 -0.546 . . . . 2.13 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.76 97.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.587 -0.696 . . . . 1.04 109.457 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.01 -178.19 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.618 -0.676 . . . . 2.57 109.411 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -90.06 136.61 32.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 3.4 109.522 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.6 21.38 57.73 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.204 -1.159 . . . . 0.53 110.204 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 24' ' ' VAL . 29.4 t -90.41 160.18 16.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -1.08 . . . . 0.45 109.475 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -83.04 117.06 22.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.56 -0.713 . . . . 2.03 109.247 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.4 m -122.75 122.18 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.564 -0.71 . . . . 0.13 109.911 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' CE ' HD21 ' A' ' 11' ' ' LEU . 3.1 ttpt -79.33 117.35 20.23 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.581 -0.896 . . . . 0.9 108.581 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 12' ' ' ARG . 21.5 mm -64.29 131.98 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.659 -0.651 . . . . 0.12 109.636 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -119.47 31.23 6.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.502 -0.749 . . . . 0.3 109.662 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -90.56 120.58 31.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -0.793 . . . . 2.09 109.094 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -58.25 -61.8 2.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.464 -0.773 . . . . 2.38 109.953 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -83.06 79.55 9.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.647 -0.658 . . . . 1.89 109.367 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.81 139.86 28.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.735 . . . . 1.13 109.608 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 19.2 t80 -65.52 -20.58 66.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.677 -0.64 . . . . 0.79 109.861 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.517 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 7.5 m0 -121.41 28.09 7.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.75 110.149 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 12' ' ' ARG . 14.6 t80 -63.65 139.27 58.75 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.11 -0.7 . . . . 0.4 109.11 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -12.36 65.96 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.342 -0.932 . . . . 0.39 110.779 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.3 159.55 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.068 -1.254 . . . . 1.4 109.485 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 57.3 t -96.19 162.37 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.143 -0.688 . . . . 0.31 109.143 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -146.24 159.68 28.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.79 -1.324 . . . . 0.21 109.79 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -92.39 116.81 29.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.641 -0.917 . . . . 0.27 109.462 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 6' ' ' SER . 23.4 t -51.25 125.48 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.353 -0.842 . . . . 0.29 110.341 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -97.08 -47.13 5.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.29 109.887 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.77 159.75 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.496 -0.752 . . . . 0.63 109.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.867 HD12 HG22 ' A' ' 36' ' ' VAL . 32.2 mm -114.54 164.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.113 -0.699 . . . . 0.77 109.113 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 27' ' ' ILE . 1.2 t70 -108.01 -171.4 1.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.504 -0.747 . . . . 1.61 109.404 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -97.06 39.38 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.533 -0.729 . . . . 3.96 109.464 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m 59.86 30.77 20.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 4.34 109.712 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.46 -30.41 58.43 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.522 -1.431 . . . . 1.76 109.522 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 34' ' ' TYR . 24.8 pt -127.28 169.55 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.58 -0.953 . . . . 1.11 109.537 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 34' ' ' TYR . 15.9 tt -67.38 -24.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 1.83 109.728 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 33' ' ' ILE . 18.1 m-85 -125.93 75.84 71.35 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.94 109.318 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 38.2 Cg_endo -83.41 -15.57 7.48 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.108 1.872 . . . . 0.67 112.192 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 HD12 ' A' ' 27' ' ' ILE . 23.4 t -88.27 112.61 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.124 -0.985 . . . . 0.64 110.686 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.9 OUTLIER -97.97 120.53 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.62 -0.881 . . . . 0.65 108.62 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 39' ' ' ARG . 22.1 t -97.88 163.68 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.507 -0.746 . . . . 0.23 109.58 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -107.85 137.03 46.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 2.75 109.113 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 78.1 m-85 -128.63 -8.7 5.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.553 -0.717 . . . . 1.26 111.324 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 57.86 22.71 8.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.017 -1.052 . . . . 2.06 109.641 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -120.92 136.61 54.91 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.908 -0.775 . . . . 2.04 108.908 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 45' ' ' TYR . 24.2 t -109.55 148.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 1.23 109.612 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -128.19 68.46 1.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.59 -0.694 . . . . 2.05 109.277 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 43' ' ' VAL . 45.9 m-85 -64.42 116.0 5.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.488 -0.757 . . . . 2.52 109.531 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -138.98 31.06 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.625 -0.672 . . . . 4.16 109.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 65.43 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.485 -1.446 . . . . 5.33 109.485 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -108.65 150.47 27.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.576 -0.955 . . . . 5.09 109.484 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -176.53 125.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.563 -0.71 . . . . 7.18 109.496 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.65 -97.1 2.0 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.586 -1.406 . . . . 6.51 109.586 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -76.8 129.28 36.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.983 . . . . 7.2 109.466 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.7 102.36 1.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.665 . . . . 5.08 109.503 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.1 -91.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.506 -1.438 . . . . 3.86 109.506 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.665 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 73.19 141.41 0.49 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.535 -1.426 . . . . 2.85 109.535 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 54' ' ' GLY . 9.9 mp -115.92 -76.25 0.58 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.992 . . . . 2.85 109.497 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' ' 43' ' ' VAL . 2.9 m-20 66.87 11.14 8.12 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.498 -0.751 . . . . 2.2 110.466 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 56' ' ' ASN . 70.8 p -155.25 130.13 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.172 -0.955 . . . . 0.47 108.71 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.3 m-20 -117.64 135.52 53.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.576 -0.703 . . . . 1.57 109.768 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' A' ' 37' ' ' ILE . 9.0 m120 -71.91 148.07 46.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.652 -0.655 . . . . 2.07 109.321 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 26.9 m-85 -157.99 143.81 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.247 -0.649 . . . . 0.17 109.247 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.53 24.22 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.889 -0.782 . . . . 0.17 108.889 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.52 -48.31 81.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.484 -0.76 . . . . 1.72 109.605 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -68.93 -17.48 63.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.23 110.356 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -79.62 -20.42 46.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 1.18 110.155 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -100.83 148.34 25.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.388 -0.82 . . . . 0.19 109.521 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 68' ' ' VAL . 20.4 tt0 -118.82 94.07 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.555 -0.716 . . . . 2.05 109.249 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.0 t -58.47 106.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.497 -0.752 . . . . 0.29 109.778 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.1 m -110.13 30.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.551 -0.718 . . . . 0.73 109.461 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 CA-C-O 117.988 -1.451 . . . . 2.21 109.539 -179.953 . . . . . . . . 0 0 . 1 stop_ save_